🇯🇵 Japan Country × Condition
gastric adenocarcinoma Clinical Trials in Japan
Active clinical trials for gastric adenocarcinoma with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT06038578 Phase 2
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Enrollment
146 pts
Country
🇯🇵 Japan
Toray Industries, Inc
View Trial → NCT07673887 Phase 3
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Enrollment
570 pts
Country
🇯🇵 Japan
Astellas Pharma Global Development,...
View Trial → Frequently Asked Questions
How many gastric adenocarcinoma clinical trials are active in Japan?
There are currently 2 active clinical trials for gastric adenocarcinoma with sites in Japan, of which 2 are actively recruiting patients.
How can I join a gastric adenocarcinoma clinical trial in Japan?
To join a gastric adenocarcinoma clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric adenocarcinoma trials in Japan?
Active gastric adenocarcinoma trials in Japan span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology